Visual Function in Subjects Implanted With Advanced Technology Intraocular Lenses

NCT ID: NCT04916041

Last Updated: 2022-07-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-06-01

Study Completion Date

2023-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Multiple intraocular lens are nowadays available for implantation after cataract surgery. They use different technology to try to improve patient spectacle independence. It is necessary to better characterise the performence of each type of lens, as well as to define how they are affected by residual refractive errors. The purpose of this study is to evaluate visual function in patients implanted with different lenses (advanced monofocals, trifocals) in order to be able to recommend the best type of lens for each patient.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lenses, Intraocular

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Vivity

Patients who have undergone bilateral implantation of Vivity intraocular lens

Cataract surgery with bilateral implantation of the same type of intraocular lens

Intervention Type DEVICE

Cataract surgery with bilateral implantation of the same type of intraocular lens

Eyhance

Patients who have received bilateral implantation of an Eyhance intraocular lens

Cataract surgery with bilateral implantation of the same type of intraocular lens

Intervention Type DEVICE

Cataract surgery with bilateral implantation of the same type of intraocular lens

EMV

Patients who have undergone bilateral implantation of Vivity intraocular lens

Cataract surgery with bilateral implantation of the same type of intraocular lens

Intervention Type DEVICE

Cataract surgery with bilateral implantation of the same type of intraocular lens

Panoptix

Patients who have undergone bilateral implantation of Panoptix intraocular lens

Cataract surgery with bilateral implantation of the same type of intraocular lens

Intervention Type DEVICE

Cataract surgery with bilateral implantation of the same type of intraocular lens

Rayner Trifocal

Patients who have undergone bilateral implantation of Rayner trifocal intraocular lens

Cataract surgery with bilateral implantation of the same type of intraocular lens

Intervention Type DEVICE

Cataract surgery with bilateral implantation of the same type of intraocular lens

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cataract surgery with bilateral implantation of the same type of intraocular lens

Cataract surgery with bilateral implantation of the same type of intraocular lens

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

Intrasurgical complications Postsurgical complications Ophthalmological disease that limits visual potential as estimated by investigator
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Clínica Rementería

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clínica Rementería

Madrid, , Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Inés Contreras

Role: primary

34913080808

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

21/365-O_P

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.